Article

Subconscious Biases in Medicine Lean Away from the Poor and Uneducated

Socioeconomic status may serve as a determinant of whether patients seek or have access to treatment for weight management, according to researchers presenting at AACE.

(©JackF, AdobeStock)

(©JackF, AdobeStock)

Socioeconomic status may serve as a determinant of whether patients seek or have access to treatment for weight management, according to a study from Mayo Clinic, The Ohio State University Wexner Medical Center and the University of Michigan, Essentia Health and Allina Health. The findings were reported at the American Association of Clinical Endocrinologists (AACE) Annual Scientific and Clinical Congress held in Los Angeles last week.

The study included 2,339 patients who completed a survey. Of these, 28.7 percent were overweight and the rest were classified as obese. Patients who earned less than $50,000 annually “reported that their PCP was less likely to have a current role in their weight management, and that they were less likely to be treated as an equal by their healthcare provider.”

Patients with a high school degree or less were less likely to feel respected, “believed that their PCP should have a role in their weight management, has a current role in their weight management, and spent enough time with them providing weight loss advice.”

REFERENCE:  Social Determinants of Health Strongly Influence the Patient-Health Care Provider Experience in Overweight and Obesity.”

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
© 2025 MJH Life Sciences

All rights reserved.